Balance sheet of Genomic Valley is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Genomic Valley is increasing.
Latest net debt of Genomic Valley is -₹0.01 Crs as of Sep-25.
This is greater than Mar-24 when it was -₹0.01 Crs.

The profit is oscillating.
The profit of Genomic Valley is ₹0.02 Crs for Mar 2024, ₹0.65 Crs for Mar 2023 and -₹0.01 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Genomic Valley latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances